Cefadroxil 500 mg Capsules Under Fasting Conditions
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative bioavailability of cefadroxil 500 mg
capsules (manufactured by Teva Pharmaceuticals USA) with that of DURICEF® 500 mg capsules
(manufactured by Bristol-Myers Squibb Company) when dosed (1 x 500 mg capsules) in normal
healthy non-smoking male and female subjects under fasting conditions.